Allscripts (MDRX)
NASDAQ:MDRX
MDRXAllscripts
$17.28
-$0.01 (-0.06%)

Allscripts Stock Analysis & Ratings

Allscripts Stock Analysis Overview

Smart Score
3
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Allscripts stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

MDRX

MDRX Stock Stats

Previous Close$17.29
Open$17.34
Bid0 x 0
Ask0 x 0
Today’s Range$17.17 - $17.55
52-Week Range$6.81 - $19.00
Volume900.86K
Average Volume1.56M
Market Cap$2.44B
Beta1.08
P/E Ratio3.8
EPS4.58
Earnings DateAug 05, 2021

Company Description

Allscripts

Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, connectivity, information solutions, and related professional services. It operates through the following segments: Clinical and Financial Solutions; Population Health; and Netsmart. The Clinical and Financial Solutions segment involves in the sale of clinical software applications and financial and information solutions. The Population Health segment offers health management and coordinated care solutions. The Netsmart segment operates in the home care and behavioral healthcare information technology field throughout the United States. The company was founded in 1986 and is headquartered in Chicago, IL.
Sector
Technology
Industry
Healthcare Providers & Services
CEO
Paul M. Black
Employees
8,400
Address
222 Merchandise Mart Plaza, Chicago, IL, 60654, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

MDRX FAQ

What was Allscripts’s price range in the past 12 months?
Allscripts lowest stock price was $6.81 and its highest was $19.00 in the past 12 months.
    What is Allscripts’s market cap?
    Allscripts’s market cap is $2.44B.
      What is Allscripts’s price target?
      The average price target for Allscripts is $17.29. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $19.00 ,the lowest forecast is $15.00. The average price target represents 0.06% Increase from the current price of $17.28.
        What do analysts say about Allscripts?
        Allscripts’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
          When is Allscripts’s upcoming earnings report date?
          Allscripts’s upcoming earnings report date is Aug 05, 2021 which is in 10 days.
            How were Allscripts’s earnings last quarter?
            Allscripts released its earnings results on Apr 29, 2021. The company reported $0.056 earnings per share for the quarter, missing the consensus estimate of $0.151 by -$0.095.
              Is Allscripts overvalued?
              According to Wall Street analysts Allscripts’s price is currently Undervalued.
                Does Allscripts pay dividends?
                Allscripts does not currently pay dividends.
                What is Allscripts’s EPS estimate?
                Allscripts’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Allscripts have?
                Allscripts has 141,170,000 shares outstanding.
                  What happened to Allscripts’s price movement after its last earnings report?
                  Allscripts reported an EPS of $0.056 in its last earnings report, missing expectations of $0.151. Following the earnings report the stock price went down -1.706%.
                    Which hedge fund is a major shareholder of Allscripts?
                    Among the largest hedge funds holding Allscripts’s share is Fisher Asset Management LLC. It holds Allscripts’s shares valued at 89M.

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis